John J. Amante

1.2k citations
15 papers · 935 indexed · 1 hit paper · h-index 11

John J. Amante

14 papers receiving 932 citations

Hit Papers

Prominin2 Drives Ferroptosis Resistance by Stimulating Ir...20192026202120232019100200300400

Peers

John J. Amante
Comparison fields: 5 of 79
  • Molecular Biology 631
  • Pulmonary and Respiratory Medicine 525
  • Cancer Research 478
  • Oncology 141
  • Biomedical Engineering 78
Replace Chen Sun with:
Chen Sun China
Leland W. K. Chung United States
Sharrell B. Lee United States
Carsten Dan Ley Denmark
Amandine David France
Francesca Pedini Italy
Pierre‐Benoit Ancey France
Elle Koren Israel
Xiaoteng Cui China
John J. Amante relative to Chen Sun China Chen Sun's profile →
Citations per field
00.5×3.6×
Chen Sun · 1×
Citations per year

Countries citing papers authored by John J. Amante

Since Specialization
Citations

This map shows the geographic impact of John J. Amante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J. Amante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J. Amante more than expected).

Fields of papers citing papers by John J. Amante

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John J. Amante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J. Amante. The network helps show where John J. Amante may publish in the future.

Co-authorship network of co-authors of John J. Amante

This figure shows the co-authorship network connecting the top 25 collaborators of John J. Amante. A scholar is included among the top collaborators of John J. Amante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John J. Amante. John J. Amante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 0
2 2
3 36
4 41
5 36
6 34
7 4
8
Prominin2 Drives Ferroptosis Resistance by Stimulating Iron Exportbreakdown →
460
9 11
10 1
11 31
12 22
13 54
14 51
15 152

About John J. Amante

John J. Amante is a scholar working on Cancer Research, Immunology and Allergy and Immunology, having authored 15 papers that have together received 935 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (4 papers), Cancer Cells and Metastasis (3 papers) and Hippo pathway signaling and YAP/TAZ (3 papers). The work is most often cited by research in Cancer Research (478 citations), Pulmonary and Respiratory Medicine (525 citations) and Molecular Biology (631 citations). John J. Amante has collaborated with scholars based in United States and Canada. Frequent co-authors include Arthur M. Mercurio, Caitlin W. Brown, Lihua Julie Zhu, Ameer L. Elaimy, Peter Chhoy, Hira Lal Goel, Christina E. Baer, Haibo Liu, Scott J. Dixon and Vincent M. Rotello. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026